(Q38361908)

English

A truncated plasminogen activator inhibitor-1 protein blocks the availability of heparin-binding vascular endothelial growth factor A isoforms

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

A truncated plasminogen activator inhibitor-1 protein blocks the availability of heparin-binding vascular endothelial growth factor A isoforms (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Mary Jo Mulligan-Kehoe

1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Hynda K Kleinman

2

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Mary Drinane

3

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Robert J Wagner

4

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Courtney Wieland

5

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Richard J Powell

6

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

language of work or name

0 references

publication date

14 October 2002

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

number of pages

13

1 reference

based on heuristic

inferred from page(s)

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

277

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

50

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

49077-49089

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Mechanisms of angiogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

Angiogenic factors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

VEGF-mediated tumour angiogenesis: a new target for cancer therapy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

Vascular endothelial growth factor is a secreted angiogenic mitogen

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

Disulfide structure of the heparin binding domain in vascular endothelial growth factor: characterization of posttranslational modifications in VEGF.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

Extracellular cleavage of the vascular endothelial growth factor 189-amino acid form by urokinase is required for its mitogenic effect.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

The fibrinolytic system of the vessel wall and its role in the control of thrombosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

On the size of the active site in proteases. I. Papain

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

Protein inhibitors of proteinases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

Sequence requirements in the reactive-center loop of plasminogen-activator inhibitor-1 for recognition of plasminogen activators.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

Structural basis of latency in plasminogen activator inhibitor-1

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

Thrombin neutralizes plasminogen activator inhibitor 1 (PAI-1) that is complexed with vitronectin in the endothelial cell matrix

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

Inactivation of plasminogen activator inhibitor-1 by specific proteolysis with stromelysin-1 (MMP-3).

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

Insights in vessel development and vascular disorders using targeted inactivation and transfer of vascular endothelial growth factor, the tissue factor receptor, and the plasminogen system.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

Plasminogen activators augment endothelial cell organization in vitro by two distinct pathways

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

Substrate behavior of plasminogen activator inhibitor-1 is not associated with a lack of insertion of the reactive site loop.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

Prevention of aneurysm development and rupture by local overexpression of plasminogen activator inhibitor-1.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

Integrin-associated protein and thrombospondin-1 as endothelial mechanosensitive death mediators

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

Endothelial cells inhibit flow-induced smooth muscle cell migration: role of plasminogen activator inhibitor-1.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

The plasminogen activation system in tumor growth, invasion, and metastasis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208757200

21 January 2018

Identifiers

10.1074/JBC.M208757200

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38361908&oldid=1769596433"